SupportLoginSign Up
Featured FeedJournalsCollectionsKeywords
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Light chain deposition disease (nodular glomerulopathy, kappa light chain deposition disease): a case report.

G A Herrera
Ultrastructural Pathology 1994 January
A typical case of kappa light chain deposition disease is detailed. Clinical and pathological findings are described. The discussion focuses on the diagnostic challenges encountered in the diagnosis of monoclonal light chain-related renal diseases. Experimental models have played a relevant role in clarifying and elucidating fundamental questions of diagnostic significance.

Full text links

Find Full Text Links for this Article

Trending Papers

Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors.Joshua J Neumiller et al.TouchREVIEWS in endocrinology. 2022 November
How we treat primary immune thrombocytopenia in adults.Xin-Guang Liu, Yu Hou, Ming HouJournal of Hematology & Oncology 2023 January 20
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.Nathan I Shapiro et al.New England Journal of Medicine 2023 January 22

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Do Not Sell My Personal InformationManage Cookie Preferences

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app